Evaxion A/S ADR EVAX

$3.33 +0.50 (17.67%)

Valuation

Market cap
25,531,000
Revenue TTM
$7,530,000
Net income TTM
$-7,710,000
PE ratio
0.00
Forward PE
—
Profit margin
-102.39%
Debt to equity
0.56

Trading

Volume
462,322
Avg volume
258,968
Day's range
$2.97 – $3.60
Shares out
9,021,000
Stochastic %K
21%
Beta
0.50
Analysts
Strong Sell
Price target
$11.25

Price

Company profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs...

Show more

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a multi-component prophylactic vaccine targeting skin and soft tissue infections with S. aureus bacteria; EVX-B2 to target multi-component prophylactic vaccine against gonorrhea bacteria; EVX-B3 to target bacterial pathogen associated with repeated infections; and EVX-V1, a multi-component prophylactic vaccine candidate for cytomegalovirus. The company was formerly known as Evaxion Biotech A/S and changed its name to Evaxion A/S in May 2025. Evaxion A/S was incorporated in 2008 and is based in Horsholm, Denmark.

Industry
Biotechnology
Sector
Healthcare
Phone
45 53 53 18 50
Website
https://evaxion.ai
Address
Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark

Latest news

Stocktwits

Manwiththeplan Oct 19, 5:00 PM
$EVAX dont sell. dont let the shorts cover
0 replies
uptrend2025 Oct 19, 4:14 PM
$EVAX Tutes loading
0 replies
MikeyYuen Oct 19, 4:14 PM
$MASK.X $APLX $ATNM $EVAX $SDEV ...
0 replies
vvvvvvrebel89130 Oct 19, 3:09 PM
$EVAX cancer vaccine ?😳😁😱👀😎
0 replies
Sean9701 Oct 19, 2:46 PM
$EVAX Great news on EVAX 🔥
0 replies
NoNoNoNoNoNoYesNo Oct 19, 2:34 PM
$EVAX this may not make a major move until later this week or next. As others have mentioned, partnership is the real goal here...not holding my breath for an announcement next week on that, but it would be a pleasant surprise. Cash runway to 2H27 is helpful to reduce likelihood of dilution.
0 replies
topstockalerts Oct 19, 1:42 PM
$EVAX the buyers seem unusually committed here.
1 replies
NoNoNoNoNoNoYesNo Oct 19, 1:40 PM
$EVAX I'm adding a bit to my position here...
0 replies